CLOV vs JBSS · rev $1.37B vs P/E 13, rev $1.18B
Clover Health Investments Corp (CLOV) versus John B Sanfilippo & Son Inc (JBSS) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
John B Sanfilippo & Son Inc (JBSS) is a packaged foods company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported JBSS revenue for 2026-06-25 was $1.18B. Net income was $61.9M. Revenue was up 6.2% from 2025-06-26 to 2026-06-25. JBSS currently screens at market cap $868.4M and trailing P/E 13.0.
CLOV currently screens at market cap $1.55B. JBSS currently screens at market cap $868.4M and trailing P/E 13.0.
Not investment advice. Open the CLOV and JBSS stock pages for the full models.
Not investment advice.